DGAP-Adhoc: QIAGEN N.V.: QIAGEN intends to return capital of US$300 million to shareholders by end of 2017

QIAGEN N.V.  / Key word(s): Capital Reorganisation/Corporate Action

28.07.2016 22:00

Disclosure of an inside information according to Article 17 MAR,
transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Ad hoc Announcement of Insider Information according to Article 17 MAR

QIAGEN intends to return capital of US$300 million to shareholders by end
of 2017

Venlo, The Netherlands, July 28, 2016 - QIAGEN N.V. announces that it
intends to return capital to its shareholders in the additional amount of
approximately US$200 million by early 2017. Considering the share
repurchase program announced on 27th April 2016 of up to a total of US$100
million, which has not yet been started, the total return figure is
expected to be approximately US$300 million. Both the manner and structure
and the exact timing of the capital return are still subject to the
approval of QIAGEN's Managing Board and Supervisory Board and will be
announced separately at a later stage.

In addition, QIAGEN gives notice that the already announced repurchase
program of up to US$100 million is now intended to be completed before the
end of 2017. Details of the repurchase program will be announced before its
actual commencement in line with Article 5 Section (1) and (6) of the EU
regulation 596/2014 in conjunction with the regulatory technical standards
adopted by the European Commission (so called Safe Harbour Regulation).
Repurchased shares will be held in treasury in order to satisfy obligations
for exchangeable debt instruments and employee share-based remuneration
plans.

QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

The Netherlands

ISIN: NL0000240000

Frankfurt Stock Exchange, Regulated Market (Prime Standard)

Contacts QIAGEN N.V.:

Corporate Communications

John Gilardi, Tel: +49 2103 29 11711; ir@qiagen.com

Thomas Theuringer, Tel: +49 2013 29 11826 pr@qiagen.com


28.07.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      QIAGEN N.V.
              Hulsterweg 82
              5912 PL Venlo
              Netherlands
Phone:        +31 7735566 - 00
Fax:          +31 77 35566-58
E-mail:       qiagen@qiagen.com
Internet:     www.qiagen.com
ISIN:         NL0000240000
WKN:          901626
Indices:      TecDAX
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated
              Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
              Munich, Stuttgart, Tradegate Exchange; Terminbörse EUREX;
              London, Chicago, Nasdaq, SIX
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------